Patients with MYCN -amplified tumors tended to exhibit poorer survival outcomes than patients with non- MYCN -amplified tumors, but this difference did not reach statistical significance.
← all excerpts
A multidisciplinary team care approach improves outcomes in high-risk pediatric neuroblastoma patients.
1
—
—